Performance of an automated insulin‐glucagon delivery system versus automated insulin delivery system during challenging inpatient conditions. A single‐blind randomised controlled crossover trial
Diabetes, Obesity and Metabolism · 2026
DOI: 10.1111/dom.70577 ↗At a glance
Randomisierte kontrollierte Studie in Diabetes, Obesity and Metabolism, 2026. Written by Ajenthen G Ranjan and 7 co-authors. Institution: Diabetes Technology Research, Clinical and Translational Research, Steno Diabetes Center Copenhagen, Herlev, Denmark. Major MEDLINE topics: Diabetes Mellitus, Type 1, Glucagon, Hypoglycemic Agents, Insulin. 25 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Danish Diabetes and Endocrine Academy.
Abstract (original language)
Aims To assess the efficacy and safety of an automated insulin‐glucagon delivery system (AIGD) compared with an automated insulin delivery system (AID). Materials and methods In a 33‐h, randomised, crossover, inpatient study, 13 participants with type 1 diabetes used the DiaCon system in AIGD and AID modes. Each study period included two overnight stays and standardised challenges: receiving 50% of the calculated insulin bolus for breakfast, 100% bolus for lunch, 130% bolus for dinner, and a 45‐min unannounced bicycle exercise at 50% VO 2max . Co‐primary endpoints were (1) number of 15‐g carbohydrate treatments for plasma glucose 10.0 mmol/L (27.5 ± 14.8% vs. 29.2 ± 10.4%, p = 0.46) were similar. Mean glucose and coefficient of variation were comparable between AIGD versus AID ( p = 0.30). The post hoc analysis demonstrated that AIGD had significantly higher TIR 0–3 h after exercise and fewer hypoglycaemia events (
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Diabetes Technology Research, Clinical and Translational Research, Steno Diabetes Center Copenhagen, Herlev, Denmark.
- Danish Diabetes Academy, Odense, Denmark.
- Department of Applied Mathematics and Computer Science, Technical University of Denmark, Kongens Lyngby, Denmark.
- Novo Nordisk Foundation Center for Basic Metabolic Research and Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
ORCID profiles: Ajenthen G Ranjan, Christian Laugesen, Signe Schmidt, Jens Juul Holst
Funding
- Danish Diabetes and Endocrine Academy
Cite
APA
Ranjan, A. G., Laugesen, C., Boiroux, D., Schmidt, S., Reenberg, A. T., Holst, J. J., Jørgensen, J. B., & Nørgaard, K. (2026). Performance of an automated insulin‐glucagon delivery system versus automated insulin delivery system during challenging inpatient conditions. A single‐blind randomised controlled crossover trial. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70577
Vancouver
Ranjan AG, Laugesen C, Boiroux D, Schmidt S, Reenberg AT, Holst JJ, et al. Performance of an automated insulin‐glucagon delivery system versus automated insulin delivery system during challenging inpatient conditions. A single‐blind randomised controlled crossover trial. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70577
BibTeX
@article{Ranjan2026,
author = {Ranjan, Ajenthen G and Laugesen, Christian and Boiroux, Dimitri and Schmidt, Signe and Reenberg, Asbjørn T and Holst, Jens Juul and Jørgensen, John B and Nørgaard, Kirsten},
title = {Performance of an automated insulin‐glucagon delivery system versus automated insulin delivery system during challenging inpatient conditions. A single‐blind randomised controlled crossover trial},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
doi = {10.1111/dom.70577}
}
EUVIMED